ProQuest Associates IV LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProQuest Associates IV LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$513,000
+43.7%
6,7770.0%0.79%
+92.4%
Q1 2018$357,000
-1.4%
6,7770.0%0.41%
-14.8%
Q4 2017$362,000
-10.4%
6,7770.0%0.48%
+18.8%
Q3 2017$404,000
-24.5%
6,777
-99.8%
0.40%
-40.8%
Q2 2017$535,000
-99.8%
3,652,2840.0%0.68%
-99.2%
Q1 2017$302,920,000
-3.4%
3,652,284
-7.6%
91.10%
+2.6%
Q4 2016$313,558,000
+2.2%
3,952,078
-9.8%
88.77%
+5.0%
Q3 2016$306,793,000
+65.5%
4,382,764
-8.3%
84.52%
+12.1%
Q2 2016$185,423,000
-4.2%
4,780,1880.0%75.43%
+0.3%
Q1 2016$193,598,000
-54.3%
4,780,1880.0%75.20%
-8.1%
Q4 2015$423,859,000
+19.8%
4,780,1880.0%81.80%
-2.3%
Q3 2015$353,877,000
-8.4%
4,780,1880.0%83.76%
+5.5%
Q2 2015$386,526,000
+93.0%
4,780,1880.0%79.39%
+21.5%
Q1 2015$200,242,000
+172.5%
4,780,188
+0.8%
65.32%
+75.4%
Q4 2014$73,488,0004,741,18737.25%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 112,666$1,7770.65%
Smith, Graham & Co., Investment Advisors, LP 273,099$4,306,7710.54%
BRANDES INVESTMENT PARTNERS, LP 1,134,363$17,888,9040.35%
TANG CAPITAL MANAGEMENT LLC 118,857$1,874,3750.26%
Virtus Investment Advisers, Inc. 20,867$329,0730.22%
DENALI ADVISORS LLC 32,300$509,3710.18%
Nebula Research & Development LLC 11,473$180,9290.10%
SCOUT INVESTMENTS, INC. 131,192$1,995,4300.05%
XTX Topco Ltd 15,050$237,3390.04%
PDT Partners, LLC 19,745$311,3790.04%
View complete list of EAGLE PHARMACEUTICALS INC shareholders